These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22048794)

  • 1. Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.
    Iłżecka J
    Neurol Sci; 2012 Aug; 33(4):825-9. PubMed ID: 22048794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis.
    Iłżecka J
    Clin Biochem; 2011 Jun; 44(8-9):650-3. PubMed ID: 21349256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
    Iłżecka J
    Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Cytokine; 2002 Dec; 20(5):239-43. PubMed ID: 12550109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2012 Mar; 51(1):3-7. PubMed ID: 22919996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report.
    Iłzecka J
    Scand J Clin Lab Invest; 2008; 68(4):348-51. PubMed ID: 17852832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum heat-shock protein levels in amyotrophic lateral sclerosis.
    Miyazaki D; Nakamura A; Hineno A; Kobayashi C; Kinoshita T; Yoshida K; Ikeda S
    Neurol Sci; 2016 Aug; 37(8):1277-81. PubMed ID: 27112486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.
    Liu GT; Hwang CS; Hsieh CH; Lu CH; Chang SL; Lee JC; Huang CF; Chang HT
    Mediators Inflamm; 2013; 2013():421389. PubMed ID: 23533305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients.
    Iłzecka J
    Acta Neurol Scand; 2003 Aug; 108(2):125-9. PubMed ID: 12859290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis.
    Houi K; Kobayashi T; Kato S; Mochio S; Inoue K
    Acta Neurol Scand; 2002 Nov; 106(5):299-301. PubMed ID: 12371924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients.
    Anand A; Gupta PK; Sharma NK; Prabhakar S
    Eur J Neurol; 2012 May; 19(5):788-92. PubMed ID: 21978169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Janik P; Kwiecinski H; Sokolowska B; Niebroj-Dobosz I
    J Neural Transm (Vienna); 2010 Mar; 117(3):343-7. PubMed ID: 20012656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.